Endologix Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 falls from record high as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Endologix (ELGX) PT Lowered to $3.75 at Leerink Partners
August 13, 2018 5:42 PM EDTLeerink Partners analyst Richard Newitter lowered the price target on Endologix (NASDAQ: ELGX) to $3.75 (from $4.50) while maintaining a Market Perform rating.
... MoreEndologix (ELGX) Posts Q2 Loss of $0.28/Share; Lowers Outlook
August 9, 2018 4:43 PM EDTEndologix (NASDAQ: ELGX) reported Q2 EPS of ($0.28), $0.13 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $44.7 million versus the consensus estimate of $44.45 million.
GUIDANCE:
Endologix sees FY2018 revenue of $145-155 million, versus prior of $170-$180... More
